AI for Health Summit 2022

🇬🇧 Driving Clinical Trial Success with Transformative AI-powered Image Insights - Median Technologies Session

Nov 16, 2022 | 10:40 AM CET - 11:00 AM CET

Description

Standard drug response criteria have some limitations which can hinder understanding why a drug failed or assessing a new Mechanism of Action. Intelligent imaging is fast becoming a necessity for driving successful clinical trial insight. This Masterclass will provide real-life examples and oncology case studies to share how transformative AI-powered imaging: - Amplifies biopharma’s approach to image management - Provides better and less variable biomarker extraction - Uses automation and deep analysis of results to predict outcomes - Delivers added value to an R&D strategy

Presented By

Dr Yan Liu

Chief Medical Officer

Sébastien Jacques

Head of Imaging Lab

Teaser Sessions

5:20 pm CET - 6:20 pm CET

Startups Masterclass Stage

🇬🇧🇫🇷 Investors Tour - Startups x Investors speed meetings

⬇️ Are you a startup using AI, data in health? Go & meet +10 investors for 5mn speed meeting to present your startup! Prepare your deck and pitch up to 11 of the...

Animated by Christophe FOURLEIGNIE DUC

Chief Operating Officer

10:25 am CET - 10:40 am CET

Startups Masterclass Stage

🇬🇧 New AI solutions for improved cancer diagnosis and optimized treatment

The latest advances in AI revolutionized the field of histopathology. Tribun Health, a computational pathology pioneer, empowers pathology labs and pharma sponsors with...

AI & Computer Vision Director

12:00 pm CET - 12:10 pm CET

Startups Masterclass Stage

🇫🇷 Construire le futur de la psychiatrie de précision dans le parcours de soin de pathologies...

Current approaches to the detection, diagnosis and monitoring of psychiatric disorders rely heavily on the experience of the psychiatrist and on physician-patient...

Yannick Trescos

ResilEyes Therapeutics

CEO & Co-founder

9:55 am CET - 10:05 am CET

🇬🇧 Real World Evidence to Inform Health Decisions : Data and Methodological Considerations for...

VP Analytics And Insight RWE